Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity

Low-density lipoprotein (LDL) contributes to atherogenesis and cardiovascular disease through interactions with peripheral blood cells, especially platelets. However, mechanisms by which LDL affects platelet activation and atherothrombosis, and how to best therapeutically target and safely prevent s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Tony J., Kohs, Tia C. L., Mueller, Paul A., Pang, Jiaqing, Reitsma, Stéphanie E., Parra-Izquierdo, Iván, Melrose, Alexander R., Yang, Liping, Choi, Jaewoo, Zientek, Keith D., Sviridov, Denis O., Larson, Mark K., Williams, Craig D., Pamir, Nathalie, Shatzel, Joseph J., Reddy, Ashok P., Kievit, Paul, Remaley, Alan T., Stevens, Jan F., Hinds, Monica T., McCarty, Owen J. T., Aslan, Joseph E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139943/
https://www.ncbi.nlm.nih.gov/pubmed/36219587
http://dx.doi.org/10.1182/bloodadvances.2022007169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139943/
https://www.ncbi.nlm.nih.gov/pubmed/36219587
http://dx.doi.org/10.1182/bloodadvances.2022007169

Ejemplares similares